Task 3.8
GMP-compliant labelling of nanobodies, peptides, small molecules, minibodies and antibodies...
Description
All compounds that will be the subject of clinical studies in WP6 will be labelled in a GMP-compliant manner (see section 4 describing radiochemistry experience and availability of techniques at GMP level at the different sites). Transfer of technolo...
General Design
- Type
- Cohort study
- Start/End data collection
- not available
Organisations
Lead organisations
- EBERHARD KARLS UNIVERSITAET TUEBINGENGermanyhttps://uni-tuebingen.de/en/
- STICHTING VUMC (P1)Netherlands (the)https://www.vumc.nl/
- TAKEDA DEVELOPMENT CENTRE EUROPE LTDUnited Kingdom of Great Britain and Northern Ireland (the)
- University Medical Centre Groningen (UMCG)Netherlands (the)https://www.umcg.nl/
Networks
Part of networks...